Roquette Opens New Asia Pacific Headquarters and Innovation Center in Singapore
The company has opened new facilities and an innovation center in Singapore, China that will focus on the development of plant-based products.
On Oct. 26, 2017, Roquette announced the opening of previously announced new facilities and an innovation center in Singapore, China. According to the company, the facilities will be focused on plant-based pharma, food, and nutrition products specific to regional health trends.
“As a global business leader, we know that we need to adapt our solutions to the specific needs of the different markets. By expanding our international research capability, we can ensure our products contribute to improving health and well-being of millions of consumers around the world,” said Jean-Marc Gilson, CEO of Roquette, in a company press release. “Our facilities in Singapore will allow us to explore new ways to address specific health and nutrition needs of Asian customers and consumers through plant-based ingredients such as sugar alternatives, vegetal proteins or pharmaceutical excipients, among many others.”
Features of the new facilities include a research laboratory, customer technical services, and a new regional headquarters, and will enable the company to partner with customers, universities, and research institutions for solutions, such as Singapore’s Agency for Science, Technology and Research (A*STAR) or the National University of Singapore.
This latest announcement follows a series of recent global investments by the company, including the September 2017 acquisition of Itacel, previously an excipient division of Blanver, a Brazilian multinational company.
Source: Roquette
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
